Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck

Clinical trial NCT02289209 · COMPLETED

Trial details

NCT number: NCT02289209
Sponsor: Dan Zandberg
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Head and Neck Cancer Carcinoma, Squamous Cell of Head and Neck

Start date: 2016-03-09
Primary completion: 2023-08-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.